A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).

Exclusion Criteria

• •More than 2 exacerbations of COPD requiring treatment with oral steroids in the preceding year or hospitalization for the treatment of COPD within 3 months of screening or more than twice during the preceding year.
• •History or presence of significant cardiovascular disease.
• •ECG abnormalities.
• •Significant concomitant clinical disease that could interfere with the conduct, safety or interpretation of results of this study.
• •Evidence of organ or blood disorders.